Antibodies to tumor associated complex N-glycans with terminal GlcNAcβ residues and methods of use thereof
Abstract:
The present disclosure relates to antibodies specific tumor associated complex N-glycans with terminal GlcNAcβ residues and methods for detecting a tumor in a subject. The present disclosure also relates to therapeutic antibodies specific for tumor associated complex N-glycans with terminal GlcNAcβ residues.
Information query
Patent Agency Ranking
0/0